"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","7/61","134/10891",9.15287370614576e-06,0.00183185535857979,0.00135277772298222,"CD300E/CXADR/LAIR1/LILRB4/NECTIN2/NPDC1/PILRA",7
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","4/61","29/10891",1.90499972679591e-05,0.00183185535857979,0.00135277772298222,"TNFRSF1A/TNFRSF1B/TNFRSF6B/TNFSF13B",4
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","6/61","102/10891",2.13006437044162e-05,0.00183185535857979,0.00135277772298222,"LTBR/TNFRSF11A/TNFRSF1A/TNFRSF1B/TNFRSF6B/TNFSF13B",6
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","5/61","78/10891",7.19848734829934e-05,0.00464302433965307,0.00342875318432153,"AREG/EGFR/FGF23/FGFR2/HGF",5
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3/61","18/10891",0.000128498093273302,0.00570548438214847,0.0042133523997098,"LTBR/TNFRSF11A/TNFSF13B",3
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","4/61","47/10891",0.000132685683305778,0.00570548438214847,0.0042133523997098,"CSF1/IL10RB/TNFRSF1A/TNFRSF1B",4
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","5/61","104/10891",0.000280570742428419,0.00958383654116141,0.00707741498959696,"AREG/EGFR/FGF23/FGFR2/HGF",5
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","5/61","106/10891",0.000306551817547952,0.00958383654116141,0.00707741498959696,"AREG/EGFR/FGF23/FGFR2/HGF",5
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","5/61","108/10891",0.00033431987934284,0.00958383654116141,0.00707741498959696,"CKAP4/CSF1/FGF23/FSTL3/IGFBP4",5
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","5/61","113/10891",0.000412085356479829,0.0106318021971796,0.00785131047608938,"AREG/EGFR/FGF23/FGFR2/HGF",5
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","3/61","30/10891",0.000609472570090491,0.014064180002415,0.0103860325599229,"EFNA1/EFNA4/EPHA2",3
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","5/61","125/10891",0.000654147907089069,0.014064180002415,0.0103860325599229,"CKAP4/CSF1/FGF23/FSTL3/IGFBP4",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","9/61","473/10891",0.00118065680263598,0.0234314965446217,0.0173035531398471,"CSF1/HAVCR2/HGF/IL10RB/IL15/IL18R1/LGALS9/TNFRSF1A/TNFRSF1B",9
"R-HSA-3371378","R-HSA-3371378","Regulation by c-FLIP","2/61","11/10891",0.0016429546162219,0.0264926431865781,0.0195641306273792,"TNFRSF10A/TNFRSF10B",2
"R-HSA-5218900","R-HSA-5218900","CASP8 activity is inhibited","2/61","11/10891",0.0016429546162219,0.0264926431865781,0.0195641306273792,"TNFRSF10A/TNFRSF10B",2
"R-HSA-69416","R-HSA-69416","Dimerization of procaspase-8","2/61","11/10891",0.0016429546162219,0.0264926431865781,0.0195641306273792,"TNFRSF10A/TNFRSF10B",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/61","44/10891",0.00188048611421736,0.0281570975272288,0.0207932870356116,"HAVCR2/IL15/LGALS9",3
"R-HSA-6803211","R-HSA-6803211","TP53 Regulates Transcription of Death Receptors and Ligands","2/61","12/10891",0.00196444866469038,0.0281570975272288,0.0207932870356116,"TNFRSF10A/TNFRSF10B",2
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","2/61","13/10891",0.00231326738343248,0.029841149246279,0.0220369156000674,"AREG/EGFR",2
"R-HSA-190375","R-HSA-190375","FGFR2c ligand binding and activation","2/61","13/10891",0.00231326738343248,0.029841149246279,0.0220369156000674,"FGF23/FGFR2",2
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","2/61","14/10891",0.00268910474887129,0.0330375726289901,0.024397391455925,"AREG/EGFR",2
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","3/61","51/10891",0.00287590019658626,0.0337264659417843,0.0249061213197184,"EFNA1/EFNA4/EPHA2",3
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","2/61","17/10891",0.00397570548615657,0.0410292806171358,0.0302990607576564,"TNFRSF10A/TNFRSF10B",2
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","2/61","17/10891",0.00397570548615657,0.0410292806171358,0.0302990607576564,"AREG/EGFR",2
"R-HSA-2033519","R-HSA-2033519","Activated point mutants of FGFR2","2/61","17/10891",0.00397570548615657,0.0410292806171358,0.0302990607576564,"FGF23/FGFR2",2
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","2/61","18/10891",0.00445660641026698,0.0425853501425511,0.0314481777878489,"FGF23/FGFR2",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/61","18/10891",0.00445660641026698,0.0425853501425511,0.0314481777878489,"EGFR/GAST",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","6/61","280/10891",0.00464660417077887,0.0428151384307482,0.031617870485375,"AREG/EGFR/FGF23/FGFR2/GFRA1/HGF",6
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","2/61","19/10891",0.00496303261808851,0.0429585063130882,0.0317237439521378,"CTSL/HAVCR1",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","6/61","286/10891",0.00514811573527972,0.0429585063130882,0.0317237439521378,"AREG/EGFR/FGF23/FGFR2/GFRA1/HGF",6
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","8/61","482/10891",0.00519405299872201,0.0429585063130882,0.0317237439521378,"BST2/CHI3L1/CKAP4/LAIR1/NPC2/PIGR/PLAUR/TNFRSF1B",8
"R-HSA-1442490","R-HSA-1442490","Collagen degradation","3/61","64/10891",0.00546507602554741,0.0429585063130882,0.0317237439521378,"COL6A3/CTSL/MMP12",3
"R-HSA-190241","R-HSA-190241","FGFR2 ligand binding and activation","2/61","20/10891",0.00549469266795314,0.0429585063130882,0.0317237439521378,"FGF23/FGFR2",2
